Living the vision that drives our success

Our Vision: To be the North American leader in neurology through the quality of our people, the quality of our products and our focus on the patient. Our people bring the vision to life and make it meaningful because everyone at Teva Neuroscience is here for the same reason: to help people with neurological and auto-immune disorders live more independent and rewarding lives.

Product Highlights

COPAXONE ®

The first non-interferon drug therapy indicated for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS).

Learn more
Azilect ®

The only once-daily treatment for Parkinson's disease, approved for both the early and more advanced stages of the disease.

Learn more
Frova ®

A unique treatment that provides lasting relief for migraines of long duration.

Learn more


Results of ADAGIO Study with Azilect® in Parkinson’s Disease Published in New England Journal of Medicine.

Learn more

Teva Pharmaceutical Industries Ltd. Press Release

New England Journal of Medicine